Schedule of Earnings Per Share, Basic and Diluted |
The following table provides the inputs to the calculations of basic and diluted earnings per common share (share amounts not in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | June 28, 2025 | | June 29, 2024 | | June 28, 2025 | | June 29, 2024 | Income (loss) from continuing operations | $ | (365,849) | | | $ | 8,173 | | | $ | (397,801) | | | $ | 6,603 | | Income from continuing operations attributable to redeemable noncontrolling interest | 18 | | | — | | | 36 | | | — | | Income (loss) from continuing operations attributable to RYAM | (365,867) | | | 8,173 | | | (397,837) | | | 6,603 | | Redeemable noncontrolling interest adjustment to redemption value | (481) | | | — | | | (889) | | | — | | Income (loss) from continuing operations attributable to RYAM common stockholders | (366,348) | | | 8,173 | | | (398,726) | | | 6,603 | | Income from discontinued operations, net of tax attributable to RYAM | 2,670 | | | 3,217 | | | 2,670 | | | 3,217 | | Net income (loss) attributable to RYAM common stockholders | $ | (363,678) | | | $ | 11,390 | | | $ | (396,056) | | | $ | 9,820 | | | | | | | | | | Weighted average shares used in determining basic earnings per common share | 66,875,897 | | | 65,716,362 | | | 66,551,962 | | | 65,582,651 | | Dilutive effect of: | | | | | | | | Stock options | — | | | — | | | — | | | 3 | | Performance and restricted stock | — | | | 3,073,949 | | | — | | | 2,423,674 | | Weighted average shares used in determining diluted earnings per common share | 66,875,897 | | | 68,790,311 | | | 66,551,962 | | | 68,006,328 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share |
Anti-dilutive instruments excluded from the computation of diluted earnings per share included (not in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | June 28, 2025 | | June 29, 2024 | | June 28, 2025 | | June 29, 2024 | Stock options | — | | | — | | | — | | | 1,497 | | Performance and restricted stock | 2,760,125 | | | 421 | | | 2,760,125 | | | 6,376 | | Total anti-dilutive instruments | 2,760,125 | | | 421 | | | 2,760,125 | | | 7,873 | |
|